{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:34:18Z","timestamp":1774690458447,"version":"3.50.1"},"reference-count":46,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Neurosarcoidosis is an uncommon and multiform clinical entity. Its presentation as an isolated longitudinal extensive transverse myelitis (LETM) is rare and challenging to identify. We report a case of LETM in a 60-year-old patient with no significant systemic symptoms nor relevant medical history. The peculiar spinal magnetic resonance imaging finding characterized by a posterior and central canal subpial contrast enhancement, the so-called \u201ctrident sign,\u201d together with chest computed tomography scan and lymph node biopsy led to the diagnosis of sarcoidosis. We also discuss the main differential diagnoses of LETM and therapeutic options for sarcoidosis-related myelitis.<\/jats:p>","DOI":"10.1515\/tnsci-2022-0231","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T16:42:45Z","timestamp":1658853765000},"page":"191-197","source":"Crossref","is-referenced-by-count":8,"title":["Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach"],"prefix":"10.1515","volume":"13","author":[{"given":"Alessandra","family":"Cicia","sequence":"first","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemellli IRCCS, UOC Neurologia , Rome , Italy"},{"name":"Universit\u00e0 Cattolica del Sacro Cuore, Istituto di Neurologia, Centro di Ricerca per la Sclerosi Multipla (CERSM) , Largo Agostino Gemelli 8, 00168 , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Nociti","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemellli IRCCS, UOC Neurologia , Rome , Italy"},{"name":"Universit\u00e0 Cattolica del Sacro Cuore, Istituto di Neurologia, Centro di Ricerca per la Sclerosi Multipla (CERSM) , Largo Agostino Gemelli 8, 00168 , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assunta","family":"Bianco","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemellli IRCCS, UOC Neurologia , Rome , Italy"},{"name":"Universit\u00e0 Cattolica del Sacro Cuore, Istituto di Neurologia, Centro di Ricerca per la Sclerosi Multipla (CERSM) , Largo Agostino Gemelli 8, 00168 , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"De Fino","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemellli IRCCS, UOC Neurologia , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Carlomagno","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemellli IRCCS, UOC Neurologia , Rome , Italy"},{"name":"Universit\u00e0 Cattolica del Sacro Cuore, Istituto di Neurologia, Centro di Ricerca per la Sclerosi Multipla (CERSM) , Largo Agostino Gemelli 8, 00168 , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Mirabella","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemellli IRCCS, UOC Neurologia , Rome , Italy"},{"name":"Universit\u00e0 Cattolica del Sacro Cuore, Istituto di Neurologia, Centro di Ricerca per la Sclerosi Multipla (CERSM) , Largo Agostino Gemelli 8, 00168 , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Lucchini","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemellli IRCCS, UOC Neurologia , Rome , Italy"},{"name":"Universit\u00e0 Cattolica del Sacro Cuore, Istituto di Neurologia, Centro di Ricerca per la Sclerosi Multipla (CERSM) , Largo Agostino Gemelli 8, 00168 , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"2022120618354258806_j_tnsci-2022-0231_ref_001","doi-asserted-by":"crossref","unstructured":"Tobin WO, Weinshenker BG, Lucchinetti CF. Longitudinally extensive transverse myelitis. Curr Opin Neurol. 2014;27:279\u201389.","DOI":"10.1097\/WCO.0000000000000093"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_002","doi-asserted-by":"crossref","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177\u201389.","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_003","doi-asserted-by":"crossref","unstructured":"Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis-diagnosis and management. QJM. 1999;92:103\u201317.","DOI":"10.1093\/qjmed\/92.2.103"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_004","doi-asserted-by":"crossref","unstructured":"Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26:527\u201334.","DOI":"10.1097\/MCP.0000000000000715"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_005","doi-asserted-by":"crossref","unstructured":"Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004;3:397\u2013407.","DOI":"10.1016\/S1474-4422(04)00805-1"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_006","doi-asserted-by":"crossref","unstructured":"Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016;16:220.","DOI":"10.1186\/s12883-016-0741-x"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_007","doi-asserted-by":"crossref","unstructured":"Wengert O, Rothenfusser-Korber E, Vollrath B, Bohner G, Scheibe F, Otto C, et al. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity. J Neurol Sci. 2013;335:124\u201330.","DOI":"10.1016\/j.jns.2013.09.008"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_008","doi-asserted-by":"crossref","unstructured":"Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909\u201317.","DOI":"10.1001\/archneur.1985.04060080095022"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_009","doi-asserted-by":"crossref","unstructured":"Krumholz A, Stern BJ. Neurologic manifestations of sarcoidosis. Handb Clin Neurol. 2014;119:305\u201333.","DOI":"10.1016\/B978-0-7020-4086-3.00021-7"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_010","doi-asserted-by":"crossref","unstructured":"Duhon BS, Shah L, Schmidt MH. Isolated intramedullary neurosarcoidosis of the thoracic spine: case report and review of the literature. Eur Spine J. 2012;21;(Suppl 4):S390\u20135.","DOI":"10.1007\/s00586-011-1842-2"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_011","doi-asserted-by":"crossref","unstructured":"Wang L, Li Y. Longitudinal ultra-extensive transverse myelitis as a manifestation of neurosarcoidosis. J Neurol Sci. 2015;355:64\u20137.","DOI":"10.1016\/j.jns.2015.05.017"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_012","doi-asserted-by":"crossref","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805\u201315.","DOI":"10.1016\/S1474-4422(07)70216-8"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_013","doi-asserted-by":"crossref","unstructured":"Flanagan EP. Neuromyelitis optica spectrum disorder and other non-multiple sclerosis central nervous system inflammatory diseases. Contin (Minneap Minn). 2019;25:815\u201344.","DOI":"10.1212\/CON.0000000000000742"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_014","doi-asserted-by":"crossref","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84:1165\u201373.","DOI":"10.1212\/WNL.0000000000001367"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_015","doi-asserted-by":"crossref","unstructured":"Dutra BG, da Rocha AJ, Nunes RH, Maia ACMJ. Neuromyelitis optica spectrum disorders: Spectrum of MR imaging findings and their differential diagnosis. Radiographics. 2018;38:169\u201393.","DOI":"10.1148\/rg.2018170141"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_016","doi-asserted-by":"crossref","unstructured":"Yonezu T, Ito S, Mori M, Ogawa Y, Makino T, Uzawa A, et al. \u201cBright spotty lesions\u201d on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Mult Scler. 2014;20:331\u20137.","DOI":"10.1177\/1352458513495581"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_017","doi-asserted-by":"crossref","unstructured":"Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, et al. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019;76:301\u20139.","DOI":"10.1001\/jamaneurol.2018.4053"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_018","doi-asserted-by":"crossref","unstructured":"Dumrikarnlert C, Siritho S, Chulapimphan P, Ngamsombat C, Satukijchai C, Prayoonwiwat N. The characteristics of spinal imaging in different types of demyelinating diseases. J Neurol Sci. 2017;372:138\u201343.","DOI":"10.1016\/j.jns.2016.11.035"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_019","doi-asserted-by":"crossref","unstructured":"Flanagan EP, Lennon VA, Pittock SJ. Autoimmune myelopathies. Contin (Minneap Minn). 2011;17:776\u201399.","DOI":"10.1212\/01.CON.0000403795.20914.6c"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_020","doi-asserted-by":"crossref","unstructured":"Mondal R, Deb S, Shome G, Ganguly U, Lahiri D, Benito-Le\u00f3n J. COVID-19 and emerging spinal cord complications: A systematic review. Mult Scler Relat Disord. 2021;51:102917.","DOI":"10.1016\/j.msard.2021.102917"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_021","doi-asserted-by":"crossref","unstructured":"Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clin Med (Lond). 2021;21:e535\u20138.","DOI":"10.7861\/clinmed.2021-0470"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_022","doi-asserted-by":"crossref","unstructured":"Pagenkopf C, S\u00fcdmeyer M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol. 2021;358:577606.","DOI":"10.1016\/j.jneuroim.2021.577606"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_023","doi-asserted-by":"crossref","unstructured":"Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, et al. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011;76:2089\u201395.","DOI":"10.1212\/WNL.0b013e31821f468f"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_024","doi-asserted-by":"crossref","unstructured":"Flanagan EP, Marsh RW, Weinshenker BG. Teaching neuroimages: \u201cpancake-like\u201d gadolinium enhancement suggests compressive myelopathy due to spondylosis. Neurology. 2013;80:e229.","DOI":"10.1212\/WNL.0b013e318293e346"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_025","doi-asserted-by":"crossref","unstructured":"Atkinson JL, Miller GM, Krauss WE, Marsh WR, Piepgras DG, Atkinson PP, et al. Clinical and radiographic features of dural arteriovenous fistula, a treatable cause of myelopathy. Mayo Clin Proc. 2001;76:1120\u201330.","DOI":"10.4065\/76.11.1120"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_026","doi-asserted-by":"crossref","unstructured":"Graham D, McCarthy A, Kavanagh E, O\u2019Rourke K, Lynch T. Teaching NeuroImages: longitudinally extensive transverse myelitis in neuro-Behcet disease. Neurology. 2013;80:e189\u201390.","DOI":"10.1212\/WNL.0b013e3182904d2e"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_027","doi-asserted-by":"crossref","unstructured":"Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, et al. Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol. 2016;79:437\u201347.","DOI":"10.1002\/ana.24582"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_028","doi-asserted-by":"crossref","unstructured":"Kasliwal MK, Harbhajanka A, Nag S, O\u2019Toole JE. Isolated spinal neurosarcoidosis: An enigmatic intramedullary spinal cord pathology-case report and review of the literature. J Craniovertebr Junction Spine. 2013;4:76\u201381.","DOI":"10.4103\/0974-8237.128536"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_029","doi-asserted-by":"crossref","unstructured":"Zalewski NL, Krecke KN, Weinshenker BG, Aksamit AJ, Conway BL, McKeon A, et al. Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology. 2016;87:743\u20134.","DOI":"10.1212\/WNL.0000000000002992"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_030","doi-asserted-by":"crossref","unstructured":"Jolliffe EA, Keegan BM, Flanagan EP. Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis. Mult Scler Relat Disord. 2018;23:7\u20138.","DOI":"10.1016\/j.msard.2018.04.012"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_031","doi-asserted-by":"crossref","unstructured":"Gerke AK. Treatment of sarcoidosis: a multidisciplinary approach. Front Immunol. 2020;11:545413.","DOI":"10.3389\/fimmu.2020.545413"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_032","doi-asserted-by":"crossref","unstructured":"Brito-Zer\u00f3n P, P\u00e9rez-Alvarez R, Pallar\u00e9s L, Retamozo S, Baughman RP, Ramos-Casals M. Sarcoidosis: an update on current pharmacotherapy options and future directions. Expert Opin Pharmacother. 2016;17:2431\u201348.","DOI":"10.1080\/14656566.2016.1258061"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_033","doi-asserted-by":"crossref","unstructured":"Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J. 2006;28:627\u201336.","DOI":"10.1183\/09031936.06.00105805"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_034","doi-asserted-by":"crossref","unstructured":"Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, et al. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017;89:2092\u2013100.","DOI":"10.1212\/WNL.0000000000004644"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_035","doi-asserted-by":"crossref","unstructured":"Androdias G, Maillet D, Marignier R, Pin\u00e8de L, Confavreux C, Broussolle C, et al. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology. 2011;76:1168\u201372.","DOI":"10.1212\/WNL.0b013e318212aafb"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_036","doi-asserted-by":"crossref","unstructured":"Baughman RP, Judson MA. Relapses of sarcoidosis: what are they and can we predict who will get them? Eur Respir J. 2014;43:337\u20139.","DOI":"10.1183\/09031936.00138913"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_037","doi-asserted-by":"crossref","unstructured":"Russell E, Luk F, Manocha S, Ho T, O\u2019Connor C, Hussain H. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy. Semin Arthritis Rheum. 2013;43:119\u201324.","DOI":"10.1016\/j.semarthrit.2012.10.008"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_038","doi-asserted-by":"crossref","unstructured":"Kidd DP. Neurosarcoidosis: clinical manifestations, investigation and treatment. Pract Neurol. 2020;20:199\u2013212.","DOI":"10.1136\/practneurol-2019-002349"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_039","doi-asserted-by":"crossref","unstructured":"Mustafa R, Passe TJ, Lopez-Chiriboga AS, Weinshenker BG, Krecke KN, Zalewski NL, et al. Utility of MRI enhancement pattern in myelopathies with longitudinally extensive T2 lesions. Neurol Clin Pract. 2021;11:e601\u201311.","DOI":"10.1212\/CPJ.0000000000001036"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_040","doi-asserted-by":"crossref","unstructured":"Asnafi S, Morris PP, Sechi E, Pittock SJ, Weinshenker BG, Palace J, et al. The frequency of longitudinally extensive transverse myelitis in MS: A population-based study. Mult Scler Relat Disord. 2020;37:101487.","DOI":"10.1016\/j.msard.2019.101487"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_041","doi-asserted-by":"crossref","unstructured":"Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016;15:292\u2013303.","DOI":"10.1016\/S1474-4422(15)00393-2"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_042","doi-asserted-by":"crossref","unstructured":"Sarbu N, Shih RY, Jones RV, Horkayne-Szakaly I, Oleaga L, Smirniotopoulos JG. White matter diseases with radiologic-pathologic correlation. Radiographics. 2016;36:1426\u201347.","DOI":"10.1148\/rg.2016160031"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_043","unstructured":"Gilbertson JR, Miller GM, Goldman MS, Marsh WR. Spinal dural arteriovenous fistulas: MR and myelographic findings. AJNR Am J Neuroradiol. 1995;16:2049\u201357."},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_044","doi-asserted-by":"crossref","unstructured":"Nedeltchev K, Loher TJ, Stepper F, Arnold M, Schroth G, Mattle HP, et al. Long-term outcome of acute spinal cord ischemia syndrome. Stroke. 2004;35:560\u20135.","DOI":"10.1161\/01.STR.0000111598.78198.EC"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_045","doi-asserted-by":"crossref","unstructured":"Masson C, Pruvo JP, Meder JF, Cordonnier C, Touz\u00e9 E, De La Sayette V, et al. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry. 2004;75:1431\u20135.","DOI":"10.1136\/jnnp.2003.031724"},{"key":"2022120618354258806_j_tnsci-2022-0231_ref_046","doi-asserted-by":"crossref","unstructured":"Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, et al. Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis. Jama. 2019;321:175\u201387.","DOI":"10.1001\/jama.2018.20588"}],"container-title":["Translational Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0231\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0231\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:43:14Z","timestamp":1670366594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0231\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,30]]},"published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1515\/tnsci-2022-0231"],"URL":"https:\/\/doi.org\/10.1515\/tnsci-2022-0231","relation":{},"ISSN":["2081-6936"],"issn-type":[{"value":"2081-6936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}